The estimated net worth of Dr. Jerry S. Lanchbury Ph.D. is at least $24,176,071 as of 23 Sep 2021. He owns shares worth
$1,609,625 as insider, has earned $10,557,686
from insider trading and has received compensation worth at least
$12,008,760 in Myriad Genetics, Inc..
What is the salary of Jerry S. Lanchbury Ph.D.?
Dr. Jerry S. Lanchbury Ph.D. salary is $632,040 per year
as Chief Scientific Officer in Myriad Genetics, Inc..
How old is Jerry S. Lanchbury Ph.D.?
Dr. Jerry S. Lanchbury Ph.D. is 66 years old, born in 1959.
What stocks does Jerry S. Lanchbury Ph.D. currently own?
As insider, Dr. Jerry S. Lanchbury Ph.D. owns shares in one company:
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing the risks for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic Test, a DNA sequencing test to help determine the therapy for patients with metastatic breast, ovarian, metastatic pancreatic, or metastatic prostate cancer with deleterious or suspected deleterious germline BRCA variants; and MyChoice CDx Companion Diagnostic Test, a tumor test that determines homologous recombination deficiency status in patients with ovarian cancer. The company also offers Prolaris Prostate Cancer Prognostic Test, a RNA expression tumor analysis for assessing the aggressiveness of prostate cancer; EndoPredict Breast Cancer Prognostic Test, a RNA expression test for assessing the aggressiveness of breast cancer; Precise Tumor, a solution for precision oncology; and Prequel Prenatal Screen, a non-invasive prenatal screening test conducted using maternal blood to screen for severe chromosomal disorders in a fetus. In addition, it provides Foresight Carrier Screen, a prenatal test for future parents to assess their risk of passing on a recessive genetic condition to their offspring; and GeneSight Psychotropic Mental Health Medication Test, a DNA genotyping test to aid psychotropic drug selection for patients suffering from depression, anxiety, ADHD, and other mental health conditions. Myriad Genetics, Inc. has a strategic collaboration with Illumina, Inc. and Intermountain Precision Genomics for an offering of germline and somatic tumor testing services. The company was founded in 1991 and is headquartered in Salt Lake City, Utah.
Dr. Jerry S. Lanchbury Ph.D. has made 53 insider trades between 2006-2021, according to the Form 4 filled with the SEC. Most recently he sold
200 units of MYGN stock worth $7,012 on 23 Sep 2021.
The largest trade he's
ever made was exercising 90,000 units of MYGN stock
on 2 Apr 2014. As of 23 Sep 2021
he still owns at least 288,515 units of MYGN stock.
Transaction
Date
Security
Shares
Price per share
Total value
Source
Sale
Common Stock
200
$35.06
$7,012
Option
Common Stock
30,000
$35.57
$1,067,100
Sale
Common Stock
30,000
$35.57
$1,067,100
Option
Non-Qualified Stock Option (right to buy)
30,000
$35.57
$1,067,100
Option
Common Stock
50,000
$31.07
$1,553,500
Sale
Common Stock
10,000
$27.07
$270,700
Option
Non-Qualified Stock Option (right to buy)
50,000
$31.07
$1,553,500
Option
Non-Qualified Stock Option (right to buy)
28,225
$27.07
$764,051
Option
Common Stock
28,225
$27.07
$764,051
Sale
Common Stock
28,225
$27.07
$764,051
Option
Common Stock
50,000
$35.41
$1,770,350
Option
Non-Qualified Stock Option (right to buy)
50,000
$35.41
$1,770,350
Sale
Common Stock
38,225
$35.24
$1,347,164
Option
Incentive Stock Option (right to buy)
4,170
$23.98
$99,997
Option
Non-Qualified Stock Option (right to buy)
1,775
$35.07
$62,249
Option
Common Stock
50,000
$31.76
$1,588,000
Sale
Common Stock
16,225
$33.99
$551,488
Option
Common Stock
43,295
N/A
N/A
Sale
Common Stock
3,295
N/A
N/A
Option
Non-Qualified Stock Option (right to buy)
43,295
N/A
N/A
Sale
Common Stock
36,705
N/A
N/A
Option
Common Stock
50,000
$30.02
$1,501,050
Option
Non-Qualified Stock Option (right to buy)
50,000
$30.02
$1,501,050
Option
Non-Qualified Stock Option (right to buy)
50,000
N/A
N/A
Option
Common Stock
50,000
N/A
N/A
Option
Common Stock
50,000
N/A
N/A
Option
Non-Qualified Stock Option (right to buy)
50,000
N/A
N/A
Sale
Common Stock
26,705
N/A
N/A
Option
Common Stock
32,308
$29.39
$949,532
Option
Non-Qualified Stock Option (right to buy)
30,424
$32.29
$982,391
Sale
Common Stock
30,424
$32.29
$982,391
Option
Common Stock
32,308
$29.39
$949,532
Option
Incentive Stock Option (right to buy)
1,884
$26.49
$49,907
Option
Non-Qualified Stock Option (right to buy)
4,921
N/A
N/A
Option
Common Stock
6,812
N/A
N/A
Option
Non-Qualified Stock Option (right to buy)
4,921
N/A
N/A
Option
Common Stock
6,812
$30.47
$207,575
Option
Incentive Stock Option (right to buy)
1,891
N/A
N/A
Sale
Common Stock
3,973
N/A
N/A
Option
Non-Qualified Stock Option (right to buy)
50,000
$25.72
$1,286,000
Option
Common Stock
50,000
$25.72
$1,286,000
Sale
Common Stock
54,732
N/A
N/A
Sale
Common Stock
54,732
$25.54
$1,397,965
Option
Common Stock
50,000
$25.72
$1,286,000
Option
Non-Qualified Stock Option (right to buy)
19,360
$19.47
$376,939
Sale
Common Stock
19,360
$19.47
$376,939
Option
Common Stock
19,360
$19.47
$376,939
Option
Non-Qualified Stock Option (right to buy)
40,000
N/A
N/A
Option
Common Stock
40,000
N/A
N/A
Sale
Common Stock
40,000
N/A
N/A
Sale
Common Stock
74,445
N/A
N/A
Option
Incentive Stock Option (right to buy)
5,555
N/A
N/A
Option
Common Stock
80,000
N/A
N/A
Option
Common Stock
50,000
N/A
N/A
Option
Incentive Stock Option (right to buy)
3,861
N/A
N/A
Sale
Common Stock
46,139
N/A
N/A
Option
Incentive Stock Option (right to buy)
2,346
N/A
N/A
Option
Common Stock
60,000
N/A
N/A
Sale
Common Stock
57,654
N/A
N/A
Sale
Common Stock
50,962
N/A
N/A
Option
Common Stock
50,962
N/A
N/A
Option
Non-Qualified Stock Option (right to buy)
50,962
N/A
N/A
Sale
Common Stock
7,298
N/A
N/A
Option
Non-Qualified Stock Option (right to buy)
12,336
N/A
N/A
Option
Common Stock
12,336
N/A
N/A
Option
Common Stock
5,038
$41.8
$210,588
Option
Non-Qualified Stock Option (right to buy)
11,491
N/A
N/A
Option
Common Stock
11,491
N/A
N/A
Sale
Common Stock
11,491
N/A
N/A
Sale
Common Stock
940
N/A
N/A
Option
Non-Qualified Stock Option (right to buy)
940
N/A
N/A
Option
Common Stock
940
N/A
N/A
Option
Non-Qualified Stock Option (right to buy)
270
N/A
N/A
Option
Common Stock
270
N/A
N/A
Sale
Common Stock
270
N/A
N/A
Sale
Common Stock
50,000
N/A
N/A
Option
Non-Qualified Stock Option (right to buy)
60,000
$28.21
$1,692,300
Option
Non-Qualified Stock Option (right to buy)
60,000
N/A
N/A
Option
Common Stock
60,000
N/A
N/A
Option
Common Stock
60,000
$28.21
$1,692,300
Option
Common Stock
4,329
N/A
N/A
Option
Incentive Stock Option (right to buy)
1
N/A
N/A
Option
Common Stock
20,000
N/A
N/A
Sale
Common Stock
20,000
N/A
N/A
Option
Non-Qualified Stock Option (right to buy)
20,000
N/A
N/A
Sale
Common Stock
3,000
N/A
N/A
Option
Non-Qualified Stock Option (right to buy)
30,000
N/A
N/A
Option
Incentive Stock Option (right to buy)
5,324
N/A
N/A
Option
Common Stock
90,000
N/A
N/A
Option
Common Stock
34,192
N/A
N/A
Option
Non-Qualified Stock Option (right to buy)
34,192
N/A
N/A
Sale
Common Stock
10,000
N/A
N/A
Option
Non-Qualified Stock Option (right to buy)
34,192
$23.36
$798,657
Option
Common Stock
20,000
N/A
N/A
Option
Non-Qualified Stock Option (right to buy)
20,000
N/A
N/A
Sale
Common Stock
20,000
N/A
N/A
Option
Non-Qualified Stock Option (right to buy)
20,000
N/A
N/A
Option
Common Stock
29,004
$23.27
$674,981
Option
Incentive Stock Option (right to buy)
3,196
N/A
N/A
Option
Common Stock
29,004
N/A
N/A
Sale
Common Stock
3,196
N/A
N/A
Sale
Common Stock
13,100
N/A
N/A
Option
Non-Qualified Stock Option (right to buy)
29,882
N/A
N/A
Option
Common Stock
29,882
N/A
N/A
Option
Common Stock
29,882
$19.41
$580,040
Option
Non-Qualified Stock Option (right to buy)
29,882
$19.41
$580,040
Option
Non-Qualified Stock Option (right to buy)
3,900
N/A
N/A
Sale
Common Stock
3,900
N/A
N/A
Option
Common Stock
3,900
N/A
N/A
Option
Non-Qualified Stock Option (right to buy)
3,000
N/A
N/A
Sale
Common Stock
3,000
N/A
N/A
Option
Common Stock
3,000
N/A
N/A
Sale
Common Stock
5,000
N/A
N/A
Option
Common Stock
3,464
N/A
N/A
Sale
Common Stock
3,464
N/A
N/A
Option
Non-Qualified Stock Option (right to buy)
3,464
N/A
N/A
Option
Non-Qualified Stock Option (right to buy)
26,536
N/A
N/A
Option
Common Stock
26,536
N/A
N/A
Sale
Common Stock
26,536
N/A
N/A
Sale
Common Stock
21,804
$8.63
$188,169
Option
Common Stock
21,804
$8.63
$188,169
Option
Non-Qualified Stock Option (right to buy)
21,804
$8.63
$188,169
Option
Common Stock
5,000
$8.63
$43,150
Option
Incentive Stock Option (right to buy)
5,000
$8.63
$43,150
Option
Common Stock
44,314
$21.2
$939,590
Option
Non-Qualified Stock Option (right to buy)
39,040
$20.25
$790,677
Sale
Common Stock
15,668
$6
$94,008
Sale
Common Stock
5,300
$22.75
$120,575
Sale
Common Stock
4,700
$22
$103,419
Option
Common Stock
14,904
$7.27
$108,352
Option
Incentive Stock Option (right to buy)
14,904
$7.27
$108,352
Sale
Common Stock
26,428
$26.01
$687,419
Option
Common Stock
5,000
$10.28
$51,400
Option
Incentive Stock Option (right to buy)
5,000
$10.28
$51,400
Option
Common Stock
20,000
$8.49
$169,700
Option
Non-Qualified Stock Option (right to buy)
20,000
$8.49
$169,700
Sale
Common Stock
20,000
$8.49
$169,700
Option
Incentive Stock Option (right to buy)
2,500
$20.56
$51,400
Option
Common Stock
2,500
$20.56
$51,400
Option
Non-Qualified Stock Option (right to buy)
10,000
$52.43
$524,340
Option
Common Stock
10,000
$52.43
$524,340
Sale
Common Stock
2,911
$20.56
$59,850
Sale
Common Stock
10,000
$16.64
$166,400
Option
Common Stock
10,000
$16.64
$166,400
Option
Non-Qualified Stock Option (right to buy)
10,000
$16.64
$166,400
Option
Incentive Stock Option (right to buy)
5,000
$20.56
$102,800
Option
Common Stock
5,000
$20.56
$102,800
Sale
Common Stock
5,000
$16.97
$84,850
Option
Common Stock
5,000
$16.97
$84,850
Option
Non-Qualified Stock Option (right to buy)
10,000
$16.97
$169,700
Option
Incentive Stock Option (right to buy)
6,714
$17.69
$118,737
Option
Common Stock
6,714
$17.69
$118,737
Option
Non-Qualified Stock Option (right to buy)
20,000
$67.07
$1,341,480
Option
Common Stock
20,000
$67.07
$1,341,480
Sale
Common Stock
20,000
$67.07
$1,341,480
Option
Incentive Stock Option (right to buy)
3,500
$14.81
$51,835
Option
Common Stock
3,500
$14.81
$51,835
Option
Common Stock
3,000
$14.81
$44,430
Option
Incentive Stock Option (right to buy)
3,000
$14.81
$44,430
Option
Incentive Stock Option (right to buy)
9,500
$53.98
$512,801
Sale
Common Stock
1,500
$12.54
$18,810
Option
Common Stock
9,000
$53.74
$483,660
Option
Common Stock
10,036
$33.41
$335,303
Option
Non-Qualified Stock Option (right to buy)
380
$52.01
$19,764
Sale
Common Stock
9,656
$14.81
$143,005
Option
Common Stock
10,000
$47.01
$470,080
Option
Non-Qualified Stock Option (right to buy)
10,000
$47.01
$470,080
Sale
Common Stock
7,992
$47
$375,624
Sale
Common Stock
300
$14.81
$4,443
Option
Common Stock
14,400
$38.68
$557,006
Option
Non-Qualified Stock Option (right to buy)
15,000
$33.91
$508,605
Option
Common Stock
8,750
$12.54
$109,725
Sale
Common Stock
8,750
$12.54
$109,725
Option
Non-Qualified Stock Option (right to buy)
8,750
$12.54
$109,725
Sale
Common Stock
5,000
$12.54
$62,700
Option
Common Stock
5,000
$12.54
$62,700
Option
Non-Qualified Stock Option (right to buy)
5,000
$12.54
$62,700
Sale
Common Stock
4,176
$12.54
$52,367
Option
Non-Qualified Stock Option (right to buy)
4,176
$12.54
$52,367
Option
Common Stock
4,176
$12.54
$52,367
Option
Common Stock
824
$12.54
$10,333
Option
Non-Qualified Stock Option (right to buy)
824
$12.54
$10,333
Sale
Common Stock
824
$12.54
$10,333
Myriad Genetics key executives
Myriad Genetics, Inc. executives and other stock owners filed with the SEC:
